A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)
Clinical trial NCT05107128 · COMPLETED
Trial details
- NCT number
- NCT05107128
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-26
- Primary completion
- 2024-09-04
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.